Amedisys, which recently ousted its leader Chris Gerard, has appointed Scott Ginn, executive vice president and chief financial officer, as its acting chief operating officer, the company disclosed late Tuesday.
“I am delighted to have Scott Ginn serving as a trusted partner in this critical role on our leadership team,” Paul Kusserow, chairman and the newly reinstated CEO of Amedisys, said. “Scott is well-respected within Amedisys and the industry and this appointment will generate enormous enthusiasm. I am fully confident that his intimate knowledge of both Amedisys’ finance and operations will enable us to deliver strong results and continue to provide the industry’s best care to our people and our patients.”
Ginn has led financial teams at Amedisys since 2007, serving as senior VP of accounting and controller and chief accounting officer before being named CFO in 2017 and then being promoted to executive VP in 2021. As acting COO, Ginn will be responsible for all of Amedisys’ home health, hospice and personal care operations in addition to his current duties as CFO.
“I am proud to step into this position and to continue to lead the company I’ve had the privilege of serving for 15 years,” Ginn said. “I look forward to working more closely with our operators and capitalizing on the tremendous amount of opportunity ahead of us.”
Amedisys revealed late last Thursday that Gerard, who had only been CEO since April, was leaving the company, effective immediately. The company said that it was temporarily replacing him with the former CEO, Kusserow.
In Gerard’s brief tenure at the helm, the company experienced two disappointing quarters. In the most recent quarter, the company earned $1.15 a diluted share on $558.5 million in revenues. During the same period a year earlier, it earned $1.53 a share on $553.5 million in revenues. Wall Street forecast Amedisys would earn $1.22 a share in the third quarter on 579.3 million in revenues.
